{
    "title": "Regeneron revenue beats estimates on strong sales of Eylea, COVID therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10476755/Regeneron-quarterly-profit-nearly-doubles-robust-sales-COVID-19-therapy.html",
    "date": "2022-02-04",
    "keywords": [
        "revenue",
        "covid19",
        "omicron",
        "dupixent",
        "therapy",
        "antibody",
        "regencov",
        "use",
        "regeneron",
        "variant",
        "friday",
        "demand",
        "blockbuster",
        "eylea",
        "eczema",
        "eye",
        "company",
        "government",
        "agreement",
        "september",
        "refinitiv",
        "growth",
        "food",
        "drug",
        "administration",
        "emergency",
        "lack",
        "efficacy",
        "generation",
        "concern",
        "schleifer",
        "president",
        "officer",
        "profit",
        "share",
        "quarter",
        "reporting",
        "leo",
        "editing",
        "daniel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}